Recruiting NCT06490432

Pattern of Cardiac Arrhythmia in Patients With MASLD

— Observational Cardiac Arrhythmia Metabolic Dysfunction Associated Steatotic Liver Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied: The protocol lists: Transient elastography.
Who it may be relevant to: Registry conditions: Cardiac Arrhythmia, Metabolic Dysfunction Associated Steatotic Liver Disease. Basic parameters: from 18 years · All.
What needs checking: Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place: Egypt
Next step: Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Pattern of Cardiac Arrhythmia in Patients With Metabolic Dysfunction -Assocatied Steatotic Liver Disease in Sohag University Hospital.

Overview

Study the relationship between patients with MASLD and cardiac arrhythmia that could be occur in thos patients

Detailed description

Study the cardiac arrhythmia that could be occur in patients suffering form metabolic dysfunction -assocatied steatotic liver disease and risk factors of them

Interventions

Device Transient elastography
Device that measures stiffness of liver tissue

Primary outcome measures

Cardiac arrhythmia and MASLD patients [Time frame: 1 year]
Cardiac arrhythmia [Time frame: 1 year]

Eligibility criteria

Inclusion criteria

patients aged 18years or older Patients with metabolic dysfunction -assocatied steatotic liver disease

Exclusion criteria

RHD Structural heart diseases Liver diseases other than MASLD

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model: Case-only

Study locations

Egypt · 1 center

Sohag University Hospital — Sohag

Publications

Lee HH, Lee HA, Kim EJ, Kim HY, Kim HC, Ahn SH, Lee H, Kim SU. Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease. Gut. 2024 Feb 23;73(3):533-540. doi: 10.1136/gutjnl-2023-331003. PMID 37907259

Identifiers

NCT: NCT06490432 · Soh-Med-24-06-04MS

Primary sources (government registries)

ClinicalTrials.gov (US NIH)

View this study on ClinicalTrials.gov ↗